VAQTA 25 [iU]/.5mL (hepatitis A vaccine, inactivated INJECTION, SUSPENSION) 25 [iU]/.5mL

VAQTA 25 [iU]/.5mL is an inactivated hepatitis A vaccine designed for intramuscular administration. It is used to prevent hepatitis A infection, a viral liver disease. This vaccine is suitable for individuals at risk of exposure to the virus.

Strength

25 [iU]/.5mL

Pack Size

10 SYRINGE in 1 CARTON (0006-4095-02) / .5 mL in 1 SYRINGE (0006-4095-01)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

The VAQTA 25 [iU]/.5mL vaccine is primarily used to prevent hepatitis A, a viral infection that can cause liver inflammation. It is often recommended for people traveling to areas with high rates of hepatitis A, as well as for those who may be exposed to the virus through their work or lifestyle. The vaccine works by stimulating the body's immune system to produce antibodies against the hepatitis A virus.

Side Effects

Common effects of the VAQTA 25 [iU]/.5mL vaccine may include soreness, redness, or swelling at the injection site. Some individuals might experience mild fever, headache, or fatigue following vaccination. These effects are generally short-lived and resolve on their own.

Precautions & Warnings

Before receiving the VAQTA 25 [iU]/.5mL vaccine, inform your healthcare provider about any allergies, especially to yeast or neomycin, as these are components of the vaccine. Individuals with weakened immune systems should consult their healthcare provider before vaccination. Always follow the storage and handling instructions provided with the vaccine.

Avoid Interactions

The VAQTA 25 [iU]/.5mL vaccine may interact with certain medications that affect the immune system. It is important to discuss all current medications with a healthcare provider before receiving the vaccine. Alcohol consumption does not typically interact with the vaccine, but maintaining overall health is advisable.

Frequently Asked Questions

The VAQTA 25 [iU]/.5mL vaccine is used to prevent hepatitis A infection, a viral liver disease.

The VAQTA 25 [iU]/.5mL vaccine is administered intramuscularly, typically in the deltoid muscle of the upper arm.

Common side effects include soreness, redness, or swelling at the injection site, as well as mild fever, headache, or fatigue.

Individuals with severe allergies to yeast or neomycin, or those with weakened immune systems, should consult a healthcare provider before receiving the vaccine.

The vaccine should be stored in a refrigerator between 2°C and 8°C (36°F and 46°F) and protected from light.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.